Rainbow Childrens Medicare Intrinsic Value

Rainbow Childrens Medicare intrinsic value. Rainbow Childrens Medicare (RAINBOW) median intrinsic value is ₹500.58 from 10 valuation models (range ₹326–₹713), vs current price ₹1240.80 — -59.7% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse RAINBOW shareholding pattern to track promoter, FII and institutional holdings.

Market Price (CMP)
₹1240.80
Primary Intrinsic Value
₹712.80
Market Cap
₹126.6K Cr
-59.7% Downside
Median Value
₹500.58
Value Range
₹326 - ₹713
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

RAINBOW Valuation Methods Summary — DCF, Graham Number & P/E

Rainbow Childrens Medicare intrinsic value across 10 models vs current price ₹1240.80 — upside/downside and value range per method. For current market price and key ratios, visit Rainbow Childrens Medicare share price chart.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹712.80 ₹570.24 - ₹855.36 -42.6% EPS: ₹32.40, Sector P/E: 22x
Book Value Method asset ₹326.27 ₹293.64 - ₹358.90 -73.7% Book Value/Share: ₹163.14, P/B: 2.0x
Revenue Multiple Method revenue ₹436.08 ₹392.47 - ₹479.69 -64.9% Revenue/Share: ₹218.04, P/S: 2.0x
EBITDA Multiple Method earnings ₹698.04 ₹628.24 - ₹767.84 -43.7% EBITDA: ₹712.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹559.31 ₹447.45 - ₹671.17 -54.9% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹372.24 ₹335.02 - ₹409.46 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹500.58 ₹450.52 - ₹550.64 -59.7% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹620.40 ₹558.36 - ₹682.44 -50.0% ROE: 20.2%, P/E Multiple: 16x
Graham Defensive Method conservative ₹372.24 ₹335.02 - ₹409.46 -70.0% EPS: ₹32.40, BVPS: ₹163.14
Dividend Yield Method dividend ₹372.24 ₹335.02 - ₹409.46 -70.0% DPS: ₹3.50, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

RAINBOW Intrinsic Value vs Market Price — All Valuation Models

Rainbow Childrens Medicare fair value range ₹326–₹713 vs current market price ₹1240.80 across 10 valuation models. Browse RAINBOW balance sheet details for revenue, profit, balance sheet and cash flow data.

RAINBOW Intrinsic Value Analysis — Undervalued or Overvalued?

Rainbow Childrens Medicare median intrinsic value ₹500.58, current price ₹1240.80 — Trading Above Calculated Value by 59.7%, margin of safety -100.0%.

What is the intrinsic value of RAINBOW?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Rainbow Childrens Medicare (RAINBOW) is ₹500.58 (median value). With the current market price of ₹1240.80, this represents a -59.7% variance from our estimated fair value.

The valuation range spans from ₹326.27 to ₹712.80, indicating ₹326.27 - ₹712.80.

Is RAINBOW undervalued or overvalued?

Based on our multi-method analysis, Rainbow Childrens Medicare (RAINBOW) appears to be trading above calculated value by approximately 59.7%.

RAINBOW Financial Health — Key Ratios vs Industry Benchmarks

Rainbow Childrens Medicare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 20.2% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 31.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.80x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

RAINBOW Cash Flow Quality — Operating & Free Cash Flow

Rainbow Childrens Medicare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹420 Cr ₹291 Cr Positive Free Cash Flow 8/10
March 2025 ₹396 Cr ₹262 Cr Positive Free Cash Flow 8/10
March 2024 ₹321 Cr ₹208 Cr Positive Free Cash Flow 8/10
March 2023 ₹329 Cr ₹97 Cr Positive Free Cash Flow 7/10
March 2022 ₹224 Cr ₹137 Cr Positive Free Cash Flow 8/10